Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02334891
Other study ID # E2311
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 2014
Est. completion date March 30, 2021

Study information

Verified date September 2021
Source Kyoto University, Graduate School of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The purpose of this study is to investigate the patient characteristics, selection of treatment, and factors associated with clinical outcomes in Japanese patients with acutely decompensated congestive heart failure.


Description:

Congestive heart failure (CHF) has been markedly increasing in Japan due to the rapid aging of the society and the Westernization of lifestyle that facilitates the development of coronary artery disease. The prognosis of patients with CHF still remains poor, despite the recent advances in medical and surgical treatment. Elderly heart failure patients with preserved ejection and multiple comorbidity may account for significant portion among CHF patients in the real world clinical practice, however; most of previous prospective cohort studies excluded these patients. The KCHF registry, an all-comer, prospective, multicenter registry, was designed to investigate all patients who admitted to the hospital due to acutly decompensated CHF. The aim of this study was to clarify the patients characteristics , selection of treatment, and prognosis of patients with acutly decompensated CHF in the real-world clinical practice in Japan.


Recruitment information / eligibility

Status Completed
Enrollment 4056
Est. completion date March 30, 2021
Est. primary completion date March 2019
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - All patients who admitted to the participating centers due to acutly decompensated CHF defined by modified Framingham criteria - Patients who underwent heart failure treatment including intravenus drug Exclusion Criteria: - none

Study Design


Intervention

Other:
Standard
Standard management

Locations

Country Name City State
Japan Department of Cardiovascular Medicine, Kyoto University Hospital Kyoto

Sponsors (1)

Lead Sponsor Collaborator
Kyoto University, Graduate School of Medicine

Country where clinical trial is conducted

Japan, 

Outcome

Type Measure Description Time frame Safety issue
Primary hospital mortality 1-year
Secondary functional level at discharge measured by NYHA classification 1-year
Secondary improvement of dyspnea level at discharge measured by Likert scale 1-year
Secondary walking ability at discharge categorized by ambulatory, wheelchair (outdoor only), wheelchair (outdoor and indoor), bedridden 1-year
Secondary any severe ventricular arrhythmic event during hospitalization 1-year
Secondary onset of atrial fibrillation events during hospitalization 1-year
Secondary any bradyarrhythmic event during hospitalization 1-year
Secondary any stroke during hospitalization 1-year
Secondary any cardiac surgery during hospitalization 1-year
Secondary any cateter intervention during hospitalization 1-year
Secondary any device implantation during hospitalization 1-year
Secondary bleeding events during hospitalization (GUSTO definition; moderate to severe) 1-year
Secondary adverse drug events during hospitalization 1-year
Secondary infectious diseases during hospitalization 1-year
Secondary change of BNP at discharge (?30% compared to BNP at admission ) 1-year
Secondary worsening renal function at discharge (raise of Cr?0.3mg/dl compared to Cr at admission ) 1-year
Secondary usage of guideline recommended medicine during hospitalization 1-year
Secondary usage of tolvaptan during hospitalization 1-year
See also
  Status Clinical Trial Phase
Terminated NCT04115735 - His Bundle Recording From Subclavian Vein
Recruiting NCT05562037 - Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA N/A
Completed NCT05563701 - Evaluation of the LVivo Image Quality Scoring (IQS)
Recruiting NCT05865184 - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Completed NCT04037436 - Functional Exercise and Nutrition Education Program for Older Adults N/A
Recruiting NCT04703842 - Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction Phase 1/Phase 2
Terminated NCT05594940 - Heart Failure Monitoring With a Portable Ultrasound Device With Artificial Intelligence Assisted Tools: A Multi-Phase Observational Feasibility Study
Recruiting NCT04982081 - Treating Congestive HF With hiPSC-CMs Through Endocardial Injection Phase 1
Completed NCT04394754 - Evaluating Efficacy of Digital Health Technology in the Treatment of Congestive Heart Failure N/A
Active, not recruiting NCT01385176 - Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF) N/A
Not yet recruiting NCT05516290 - Evaluating Clinical Trial Experiences of Individuals With Congestive Heart Failure
Terminated NCT02788656 - Pulmonary Artery Pressure Reduction With ENTresto (Sacubitril/Valsartan) Phase 4
Completed NCT02885636 - Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial Phase 3
Completed NCT02252757 - Assess Measurements of Wireless Cardiac Output Device N/A
Terminated NCT02205411 - Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation N/A
Completed NCT01362855 - Advance Care Planning Evaluation in Hospitalized Elderly Patients
Withdrawn NCT00346177 - Stem Cell Study for Patients With Heart Failure Phase 2
Completed NCT01476995 - Prognostic Indicators as Provided by the EPIC ClearView N/A
Active, not recruiting NCT01058837 - SCD-HeFT 10 Year Follow-up N/A
Completed NCT00957541 - Evaluation of a Diagnostic Feature in a Cardiac Resynchronization Therapy (CRT) Device Phase 2